Assignee
PLIANT THERAPEUTICS INC
US·15 granted patents·16 pending applications·105 citations·filing 2017–2024
Top patents by PatentIndex Score
31 records- 0197US10696672B2Amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2017·Granted Jun 30, 2020·21 cites·34 claims
- 0296US11634418B2Amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2020·Granted Apr 25, 2023·5 cites·41 claims
- 0396US10793564B2Amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2019·Granted Oct 6, 2020·25 cites·69 claims
- 0495US12018025B2Integrin inhibitor and uses thereofPLIANT THERAPEUTICS INC·Filed 2021·Granted Jun 25, 2024·2 cites·163 claims
- 0595US11560376B2Amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2020·Granted Jan 24, 2023·6 cites·79 claims
- 0695US10604520B2N-acyl amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2017·Granted Mar 31, 2020·20 cites·52 claims
- 0794US11180494B2Substituted amino acids as integrin inhibitorsPLIANT THERAPEUTICS INC·Filed 2019·Granted Nov 23, 2021·11 cites·47 claims
- 0892US11673887B2N-acyl amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2020·Granted Jun 13, 2023·3 cites·68 claims
- 0992US11419869B2Dosage forms and regimens for amino acid compoundsPLIANT THERAPEUTICS INC·Filed 2020·Granted Aug 23, 2022·7 cites·72 claims
- 1088US11858931B2Amino acid compounds with unbranched linkers and methods of usePLIANT THERAPEUTICS INC·Filed 2022·Granted Jan 2, 2024·1 cites·54 claims
- 1186US11952376B2Substituted amino acids as integrin inhibitorsPLIANT THERAPEUTICS INC·Filed 2021·Granted Apr 9, 2024·1 cites·172 claims
- 1286US11396506B2Amino acid compounds with unbranched linkers and methods of usePLIANT THERAPEUTICS INC·Filed 2019·Granted Jul 26, 2022·3 cites·33 claims
- 1384US2025223288A1Amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1480US2024043421A1Amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1577US2024270742A1Substituted amino acids as integrin inhibitorsPLIANT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1677US2024294520A1Amino acid compounds with unbranched linkers and methods of usePLIANT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1777US2023365556A1N-acyl amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1877US2023271960A1Amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1975US2025026819A1Methods of treatment comprising antibodies binding to alpha7beta1 integrin antibodiesPLIANT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2067USRE50554EAmino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2017·Granted Aug 26, 2025·0 cites·34 claims
- 2167US2024391914A1Integrin inhibitor and uses thereofPLIANT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2266US12390463B2Dosage forms and regimens for amino acid compoundsPLIANT THERAPEUTICS INC·Filed 2022·Granted Aug 19, 2025·0 cites·33 claims
- 2365US12134642B2Antibodies binding to α7β1 integrin antibodies and compositions thereofPLIANT THERAPEUTICS INC·Filed 2020·Granted Nov 5, 2024·0 cites·15 claims
- 2464US2024245682A1Alpha-v-beta-8 integrin inhibitors and uses thereofPLIANT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2564US2025120975A1Integrin inhibitors for treatment of primary sclerosing cholangitisPLIANT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2662US2025197393A1Integrin inhibitor and uses thereofPLIANT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2761US2023293519A1Integrin inhibitors and uses thereof in combination with other agentsPLIANT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2861US2024122930A1Integrin inhibitors and uses thereof in combination with other agentsPLIANT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2958US2024350494A1Therapeutic modulation of integrinsPLIANT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3056US2023028658A1Expanded dosage regimens for integrin inhibitorsPLIANT THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3155US2023181546A1Treatment of respiratory diseases with amino acid compoundsPLIANT THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PLIANT THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →